Freeranger,

Technical charting doesn't mean squat with NNLX. There are no trends, markers, or pivot points that apply to any company without a long history of published financials and sales.

I'm not stating that to criticize the company. The current value is in the potential of a couple of technologies, not in a chart that is anchored on graphs. The N-Assay by itself is potentially worth multi-billions to the market.

Scott